0002144345-26-000001.txt : 20260714 0002144345-26-000001.hdr.sgml : 20260714 20260713185153 ACCESSION NUMBER: 0002144345-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260714 DATE AS OF CHANGE: 20260713 EFFECTIVENESS DATE: 20260714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Reticle Biosystems, Inc. CENTRAL INDEX KEY: 0002144345 ORGANIZATION NAME: EIN: 414325092 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-590613 FILM NUMBER: 261172283 BUSINESS ADDRESS: STREET 1: 2261 MARKET STREET STE 78326 CITY: SAN FRANCISCO STATE: CA ZIP: 94114 BUSINESS PHONE: 4158811831 MAIL ADDRESS: STREET 1: 2261 MARKET STREET STE 78326 CITY: SAN FRANCISCO STATE: CA ZIP: 94114 D 1 primary_doc.xml X0708 D LIVE 0002144345 Reticle Biosystems, Inc. 2261 MARKET STREET STE 78326 SAN FRANCISCO CA CALIFORNIA 94114 4158811831 DELAWARE None None Corporation true 2026 James Che 2261 MARKET STREET STE 78326 SAN FRANCISCO CA CALIFORNIA 94114 Executive Officer Director Promoter Manufacturing No Revenues 06b false 2026-06-08 false true true true Simple Agreement for Future Equity (SAFE) false 0 1000000 1000000 0 false 1 0 0 0 The proceeds of the offering will be used for general working capital purposes, which may include the payment of salaries to executive officers in the ordinary course of business. false Reticle Biosystems, Inc. /James Che/ James Che Chief Executive Officer 2026-07-13